journal article·2020-07

Antibiotic eluting poly(ester urea) films for control of a model cardiac implantable electronic device infection

Shantanu P. Nikam, Karissa Nettleton, Jeffrey I. Everitt, Hazel A. Barton, Matthew L. Becker

Acta Biomaterialia· Volume 111
Publisher page

Abstract

Cardiac implantable electronic device (CIED) infections acquired during or after surgical procedures are a major complication that are challenging to treat therapeutically, resulting in chronic and sometimes fatal infections. Localized delivery of antibiotics at the surgical site could be used to supplement traditional systemic administration as a preventative measure. Herein, we investigate a cefazolin-eluting l-valine poly(ester urea) (PEU) films as a model system for localized antibiotic delivery for CIEDs. Poly(1-VAL-8) PEU was used to fabricate a series of antibiotic-loaded films with varied loading concentrations (2%, 5%, 10% wt/wt) and thicknesses (40 µm, 80 µm, 140 µm). In vitro release measurements show thickness and loading concentration influence the amount and rate of cefazolin release. Group 10%-140 µm (load-thickness) showed 22.5% release of active pharmaceutical ingredient (API) in the first 24 h and 81.2% of cumulative percent release through day 14 and was found most effective in bacterial clearance in vitro. This group was also effective in clearing a bacterial infection in a model in vivo rat study while eliciting a limited inflammatory response. Our results suggest the feasibility of cefazolin-loaded PEU films as an effective sustained release matrix for localized delivery of antibiotics. SIGNIFICANCE STATEMENT: Implant-associated infections acquired during surgical procedures are a major complication that have proven a challenge to treat clinically, resulting in chronic and sometimes fatal infections. In this manuscript, we investigate an antibiotic-eluting L-valine poly(ester urea) (PEU) films as a model system for localized delivery of cefazolin. Significantly, we demonstrate a wide variation in temporal delivery and dosing within this family of PEUs and show that the delivery can be extended by varying the film thickness. The in vivo results show efficacy in an infected wound model and suggest antibiotic loaded PEU films function as an effective sustained release matrix for localized delivery of antibiotics across a number of clinical indications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Antimicrobial agents and applications · Polymer Surface Interaction Studies · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Microbiology of Cardiac Implantable Electronic Device Infections
2. Management of cardiac electronic device infections: challenges and outcomes10.15420/aer.2016:21:2 ↗
3. Advances in cardiac implantable electronic device infection prevention: Should we push the envelope?10.2217/fca-2018-0039 ↗
4. Microbiology and pathogenesis of cardiovascular implantable electronic device infections
5. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights10.1111/j.1540-8159.2009.02569.x ↗
6. Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivo10.1073/pnas.1613722113 ↗
7. Infected cardiac-implantable electronic devices: Prevention, diagnosis, and treatment10.1093/eurheartj/ehv060 ↗
8. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 200810.1016/j.jacc.2011.04.033 ↗
9. Reducing implant-related infections: Active release strategies10.1039/b515219b ↗
10. Management of bacteremia in patients living with cardiovascular implantable electronic devices10.1016/j.hrthm.2016.08.029 ↗
11. Reimplantation and repeat infection after cardiac-implantable electronic device infections: Experience from the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) database
12. Treatment of infections associated with surgical implants10.1056/NEJMra035415 ↗
13. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the american heart association10.1161/CIRCULATIONAHA.109.192665 ↗
14. Bacterial biofilms: From the natural environment to infectious diseases10.1038/nrmicro821 ↗
15. Treatment of Infected cardiac implantable electronic devices10.1055/s-0036-1580733 ↗
16. Molecular basis of Staphylococcus epidermidis infections10.1007/s00281-011-0296-2 ↗
17. Mortality and cost associated with cardiovascular implantable electronic device infections10.1001/archinternmed.2011.441 ↗
18. From an Infection Prevention Perspective
19. Antibiotic-containing polymers for localized, sustained drug delivery
20. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation10.1111/jce.12684 ↗
21. Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the citadel and centurion studies
22. Antibacterial envelope to prevent cardiac implantable device infection10.1056/NEJMoa1901111 ↗
23. Efficacy of a bio‐absorbable antibacterial envelope to prevent cardiac implantable electronic device infections in high‐risk subjects10.1111/jce.12768 ↗
24. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long-term infective complications10.1111/j.1540-8159.2006.00294.x ↗
25. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial
26. Phenylalanine-based poly(ester urea): Synthesis, characterization, and in vitro degradation10.1021/ma401752b ↗
27. Radiopaque, iodine functionalized, phenylalanine-based poly(ester urea)s10.1021/bm501669u ↗
28. Resorbable, amino acid-based poly(ester urea)s crosslinked with osteogenic growth peptide with enhanced mechanical properties and bioactivity10.1016/j.actbio.2012.08.035 ↗
29. OGP Functionalized Phenylalanine-Based Poly(ester urea) for Enhancing Osteoinductive Potential of Human Mesenchymal Stem Cells10.1021/acs.biomac.5b00153 ↗
30. Pilot mouse study of 1 mm inner diameter (ID) vascular graft using electrospun poly(ester urea) nanofibers10.1002/adhm.201600400 ↗
31. Influence of Sterilization Technologies on Electrospun Poly(ester urea)s for Soft Tissue Repair10.1021/acs.biomac.6b01158 ↗
32. Enhanced Rotator-Cuff Repair Using Platelet-Rich Plasma Adsorbed on Branched Poly(ester urea)s10.1021/acs.biomac.8b00725 ↗
33. Amino acid-based Poly (ester urea) copolymer films for hernia-repair applications10.1016/j.biomaterials.2018.08.003 ↗
34. Preclinical in Vitro and in Vivo Assessment of Linear and Branched l -Valine-Based Poly(ester urea)s for Soft Tissue Applications10.1021/acsbiomaterials.7b00920 ↗
35. Zwitterionic amino acid-based Poly(ester urea)s suppress adhesion formation in a rat intra-abdominal cecal abrasion model10.1016/j.biomaterials.2019.119399 ↗
36. Adhesion of Blood Plasma Proteins and Platelet-rich Plasma on L-Valine-Based Poly(ester urea)10.1021/acs.biomac.6b01195 ↗
37. Polymer solar cell by blade coating10.1016/j.orgel.2009.03.001 ↗
38. Novel HPLC method for quantitative determination of cefazolin sodium in pharmaceutical formulations
39. F.R. Cockerill, M.A. Wiker, J. Alder, M.N. Dudley, G.M. Eliopoulos, M.J. Ferraro, D.J. Hardy, D.W. Hecht, J.A. Hindler, J.B. Patel, M. Powell, J.M. Swenson, R.B. Thomson, M.M. Traczewski, J.D. Turnidge, M.P. Weinstein, B.L. Zimmer, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard — Ninth Edition, 2012.
40. Methods for in vitro evaluating antimicrobial activity: A review10.1016/j.jpha.2015.11.005 ↗
41. Antimicrobial peptide melimine coating for titanium and its in vivo antibacterial activity in rodent subcutaneous infection models10.1016/j.biomaterials.2016.01.063 ↗
42. In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices10.1111/j.1540-8159.2009.02406.x ↗
43. Tunable Shape Memory Polymers from α-Amino Acid-Based Poly (ester urea)s10.1021/acs.macromol.7b00680 ↗
44. From Form to Function: Crystallization of Active Pharmaceutical Ingredients10.1002/aic.11555 ↗
45. Higuchi equation: Derivation, applications, use and misuse10.1016/j.ijpharm.2011.03.051 ↗
46. Cardiac implantable electronic device infections: Incidence, risk factors, and the effect of the AigisRx antibacterial envelope10.1016/j.hrthm.2013.12.013 ↗
47. Antibiotic resistance of bacteria in biofilms10.1016/S0140-6736(01)05321-1 ↗
48. Combination prophylactic therapy with rifampin increases efficacy against an experimental staphylococcus epidermidis subcutaneous implant-related infection10.1128/AAC.01943-13 ↗
49. Infections of cardiovascular implantable electronic devices10.1056/NEJMcp1107675 ↗
50. 2013